AI model suggests COVID-19 will grow more infectious

SARS-CoV-2, the virus behind COVID-19, is mutating—and a new AI model suggests many of those mutations could be even more infectious.

When a virus mutates, the researchers explained, it can be benign or even make the virus less dangerous to humans. In this instance, however, many detected mutations have a significant chance of becoming more infectious strains of COVID-19.

Wei’s team has been studying COVID-19 since January, using its machine learning-based model to explore known mutations and more than 3,000 potential future mutations.

“Knowledge about the infectivity of SARS-CoV-2 is a vital factor for preventive measurements against COVID-19 and reopening the global economy,” lead researcher Guowei Wei, a professor at Michigan State University, said in a statement. “A crucial question is what are the ramifications of these mutations to COVID-19 transmission, diagnostics, prevention and treatment.”

The team’s full analysis can be read on the ArXiv preprint server.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries.